Eugene Kang
About
In The Last Decade
Eugene Kang
14 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 81
- Genetics 568
- Molecular Biology 522
- Oncology 382
- Immunology 369
- Epidemiology 315
Countries citing papers authored by Eugene Kang
This map shows the geographic impact of Eugene Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Kang more than expected).
Fields of papers citing papers by Eugene Kang
This network shows the impact of papers produced by Eugene Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Kang. The network helps show where Eugene Kang may publish in the future.
Co-authorship network of co-authors of Eugene Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Kang. A scholar is included among the top collaborators of Eugene Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Kang. Eugene Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 33 | |
| 3 | 19 | |
| 4 | 63 | |
| 5 | 44 | |
| 6 | 93 | |
| 7 | 365 | |
| 8 | 385 | |
| 9 | 0 | |
| 10 | 28 | |
| 11 | Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer. | 55 |
| 12 | 101 | |
| 13 | Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer. | 98 |
| 14 | 110 | |
| 15 | 22 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.